Wollenhaupt J, Silverfield J, Bong Lee E, et al. Tofacitinib, an Oral Janus Kinase Inhibitor, in the Treatment of Rheumatoid Arthritis: Safety and Efficacy in Open-Label, Long-Term Extension Studies over 9 Years. ACR 2017, abstract 522.
‘De uitdaging is om de fysiotherapeut met de juiste deskundigheid vindbaar te maken’
jun 2021 | Artrose, RA, Spondyloartritis